Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT05220917

Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study

Sponsor: Brigham and Women's Hospital

View on ClinicalTrials.gov

Summary

To perform an observational analysis to emulate a target trial (i.e., a hypothetical pragmatic trial that would have answered the causal question of interest) comparing the effectiveness and safety of sodium-glucose cotransporter-2 inhibitors (SGLT2i), glucagon-like peptide 1 receptor agonists (GLP-1RA), dipeptidyl peptidase-4 inhibitors (DPP-4i), and sulfonylureas (SU), at the class and individual agent level, in head-to-head comparisons in patients with type 2 diabetes (T2D).

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

781430

Start Date

2021-08-01

Completion Date

2026-07-01

Last Updated

2025-12-08

Healthy Volunteers

No

Interventions

DRUG

SGLT2 inhibitor

Any SGLT2i dispensing claim

DRUG

DPP-4 inhibitor

Any DPP-4 inhibitor claim

DRUG

GLP-1RA

Any SGLT2i dispensing claim

DRUG

2nd generation SU

Any 2nd generation SU claim

Locations (1)

Brigham and Women's Hospital

Boston, Massachusetts, United States